Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials
Journal of Epidemiology and Community Health · 2023-12 · 77 (12) · 791-801
DOI: 10.1136/jech-2023-220781 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Epidemiology and Community Health, online erschienen am 21.09.2023. Verfasst von Marilou Kiely und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Infectiology, immunology & Pediatrics, University of Montreal, Montreal, Quebec, Canada marilou.kiely@inspq.qc.ca. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canada Research Chairs, Michael Smith Health Research BC.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Despite being a vaccine-preventable disease, influenza remains a major public health threat with vaccine safety concerns reducing vaccine acceptability. Immune responses to vaccines and adverse events may differ between males and females, but most studies do not report results by sex. Using data from clinical trials, we explored sex differences in adverse events following seasonal influenza vaccines.
Methods
We obtained data for phase III randomised controlled trials identified through a systematic review and clinical trials registries, and performed a two-stage meta-analysis. Risk ratios (RR) and 95% confidence intervals (95% CI) comparing solicited reactions in females versus males were pooled using the Mantel-Haenszel method and a random-effects model. We used the ROBINS-I tool to assess risk of bias and the I 2 statistic for heterogeneity. Main analysis was stratified by age: 18–64 years and ≥65 years.
Results
The dataset for this analysis included 34 343 adults from 18 studies (12 with individual-level data and 6 with aggregate data). There was a higher risk of injection site reactions in females compared with males for both younger and older participants, with RRs of 1.29 (95% CI 1.21 to 1.37) and 1.43 (95% CI 1.28 to 1.60), respectively. Higher risk in females was also observed for systemic reactions, with RRs of 1.25 (95% CI 1.20 to 1.31) and 1.27 (95% CI 1.20 to 1.34) for younger and older participants, respectively. We also observed elevated risks of severe reactions in females, with a higher RR in younger versus older participants for systemic reactions (RRs 2.12 and 1.48, p=0.03, I 2 =79.7%). RRs were not found to vary between quadrivalent and trivalent vaccines.
Conclusion
This meta-analysis suggested a higher risk of solicited reactions following influenza vaccines for females compared with males, irrespective of age and vaccine type. Transparent communication of this risk could increase the trust in vaccines and limit vaccine hesitancy. Future studies should report results stratified by sex and explore the role of gender in the occurrence of adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Infectiology, immunology & Pediatrics, University of Montreal, Montreal, Quebec, Canada marilou.kiely@inspq.qc.ca.
- Sainte-Justine Hospital Research Center, Montreal, Quebec, Canada.
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
- Institut national de santé publique du Québec, Quebec, Quebec, Canada.
- Vaccine Evaluation Center, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
- Department of Pediatrics, University if British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Marilou Kiely, Shannon E MacDonald
Förderung
- CIHR
- Canada Research Chairs
- Michael Smith Health Research BC
- the BC Children’s Hospital Foundation
- Canadian Institutes of Health Research
Zitieren
APA
Kiely, M., Tadount, F., Lo, E., Sadarangani, M., Wei, S. Q., Rafferty, E., Quach, C., & MacDonald, S. E. (2023). Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. Journal of Epidemiology and Community Health, 77(12), 791-801. https://doi.org/10.1136/jech-2023-220781
Vancouver
Kiely M, Tadount F, Lo E, Sadarangani M, Wei SQ, Rafferty E, et al. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. Journal of Epidemiology and Community Health. 2023;77(12):791-801. doi:10.1136/jech-2023-220781
BibTeX
@article{Kiely2023,
author = {Kiely, Marilou and Tadount, Fazia and Lo, Ernest and Sadarangani, Manish and Wei, Shu Qin and Rafferty, Ellen and Quach, Caroline and MacDonald, Shannon E},
title = {Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials},
journal = {Journal of Epidemiology and Community Health},
year = {2023},
volume = {77},
number = {12},
pages = {791--801},
doi = {10.1136/jech-2023-220781}
}
EUVIMED